Hence, the association of macrophage/monocyte activation markers with disease severity and patient prognosis suggests a role for macrophage/monocyte activation in the pathogenesis of IIM-RP-ILD, especially in those with anti-MDA5 antibodies [44]. Here, IFIH1 is linked to interstitial lung disease.